Company profile
Nuage Therapeutics
We develop new selective and potent drugs for intrinsically disordered targets.
- Industry
- Biotechnology Research
- Employees
- 23
- Headquarters
- Barcelona
- Founded
- 2021
- Office locations
- 1
Nuage Therapeutics company summary
Nuage Therapeutics is a company in the Biotechnology Research industry, headquartered in Barcelona, founded in 2021. On LinkedIn the company has around 23 employees.
What technology does Nuage Therapeutics use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About Nuage Therapeutics
Nuage Therapeutics is a biotech company focused on developing small molecule inhibitors of oncogenic transcription factors. The company has a particular focus on drugging cell lineage-specific transcription factors that are known cancer dependency genes. Built on a deep understanding of transcriptional regulation and the biophysics of intrinsically-disordered proteins (IDPs), Nuage has developed technologies that enable the ‘capture’ of IDPs in higher-order, self-assembled states that present binding pockets that render these proteins amenable to small molecule drug discovery. This represents a game-changing advance that has led to the identification of functional inhibitors of multiple transcription factors that were previously considered undruggable.
Where is Nuage Therapeutics located?
Nuage Therapeutics lists 1 location.
Compare companies similar to Nuage Therapeutics
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
Nuage Therapeutics nuagetx.com | Biotechnology Research | 23 | 2021 | Barcelona |
 Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
 Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
 Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
 Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
 Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
 Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
 Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
 Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
 Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about Nuage Therapeutics
What does Nuage Therapeutics do?
Nuage Therapeutics is a biotech company focused on developing small molecule inhibitors of oncogenic transcription factors. The company has a particular focus on drugging cell lineage-specific transcription factors that are known cancer dependency genes. Built on a deep understanding of transcriptional regulation and the biophysics of intrinsically-disordered proteins (IDPs), Nuage has developed technologies that enable the ‘capture’ of IDPs in higher-order, self-assembled states that present binding pockets that render these proteins amenable to small molecule drug discovery. This represents a game-changing advance that has led to the identification of functional inhibitors of multiple transcription factors that were previously considered undruggable.
How many employees does Nuage Therapeutics have?
Nuage Therapeutics has around 23 employees on LinkedIn.
Where is Nuage Therapeutics headquartered?
Nuage Therapeutics is headquartered in Barcelona.
When was Nuage Therapeutics founded?
Nuage Therapeutics was founded in 2021.
Build a lead list from companies like Nuage Therapeutics
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.